Risperidone in the treatment of two very young children with autism

David J. Posey, Kelda H. Walsh, Gregory A. Wilson, Christopher J. McDougle

    Research output: Contribution to journalArticle

    57 Citations (Scopus)

    Abstract

    This report describes the use of risperidone in the treatment of two very young children with autistic disorder, a 29-month-old boy and a 23- month-old boy, respectively. These children presented with severe and persistent symptoms of aggression and irritability that had not responded to previous treatment. In both cases, risperidone significantly reduced aggression and improved social relatedness. One patient's treatment with risperidone was complicated by persistent tachycardia and QT(C) interval prolongation that was dose-related. Consideration should be given to the appropriate use of medication in the treatment of very young children with autism when other interventions do not prove helpful.

    Original languageEnglish
    Pages (from-to)273-276
    Number of pages4
    JournalJournal of Child and Adolescent Psychopharmacology
    Volume9
    Issue number4
    StatePublished - 1999

    Fingerprint

    Risperidone
    Autistic Disorder
    Aggression
    Therapeutics
    Tachycardia

    ASJC Scopus subject areas

    • Pharmacology (medical)
    • Psychiatry and Mental health
    • Pediatrics, Perinatology, and Child Health
    • Pharmacology, Toxicology and Pharmaceutics(all)

    Cite this

    Posey, D. J., Walsh, K. H., Wilson, G. A., & McDougle, C. J. (1999). Risperidone in the treatment of two very young children with autism. Journal of Child and Adolescent Psychopharmacology, 9(4), 273-276.

    Risperidone in the treatment of two very young children with autism. / Posey, David J.; Walsh, Kelda H.; Wilson, Gregory A.; McDougle, Christopher J.

    In: Journal of Child and Adolescent Psychopharmacology, Vol. 9, No. 4, 1999, p. 273-276.

    Research output: Contribution to journalArticle

    Posey, DJ, Walsh, KH, Wilson, GA & McDougle, CJ 1999, 'Risperidone in the treatment of two very young children with autism', Journal of Child and Adolescent Psychopharmacology, vol. 9, no. 4, pp. 273-276.
    Posey, David J. ; Walsh, Kelda H. ; Wilson, Gregory A. ; McDougle, Christopher J. / Risperidone in the treatment of two very young children with autism. In: Journal of Child and Adolescent Psychopharmacology. 1999 ; Vol. 9, No. 4. pp. 273-276.
    @article{0578dc87512c4b39b0e54da338cf4e3a,
    title = "Risperidone in the treatment of two very young children with autism",
    abstract = "This report describes the use of risperidone in the treatment of two very young children with autistic disorder, a 29-month-old boy and a 23- month-old boy, respectively. These children presented with severe and persistent symptoms of aggression and irritability that had not responded to previous treatment. In both cases, risperidone significantly reduced aggression and improved social relatedness. One patient's treatment with risperidone was complicated by persistent tachycardia and QT(C) interval prolongation that was dose-related. Consideration should be given to the appropriate use of medication in the treatment of very young children with autism when other interventions do not prove helpful.",
    author = "Posey, {David J.} and Walsh, {Kelda H.} and Wilson, {Gregory A.} and McDougle, {Christopher J.}",
    year = "1999",
    language = "English",
    volume = "9",
    pages = "273--276",
    journal = "Journal of Child and Adolescent Psychopharmacology",
    issn = "1044-5463",
    publisher = "Mary Ann Liebert Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - Risperidone in the treatment of two very young children with autism

    AU - Posey, David J.

    AU - Walsh, Kelda H.

    AU - Wilson, Gregory A.

    AU - McDougle, Christopher J.

    PY - 1999

    Y1 - 1999

    N2 - This report describes the use of risperidone in the treatment of two very young children with autistic disorder, a 29-month-old boy and a 23- month-old boy, respectively. These children presented with severe and persistent symptoms of aggression and irritability that had not responded to previous treatment. In both cases, risperidone significantly reduced aggression and improved social relatedness. One patient's treatment with risperidone was complicated by persistent tachycardia and QT(C) interval prolongation that was dose-related. Consideration should be given to the appropriate use of medication in the treatment of very young children with autism when other interventions do not prove helpful.

    AB - This report describes the use of risperidone in the treatment of two very young children with autistic disorder, a 29-month-old boy and a 23- month-old boy, respectively. These children presented with severe and persistent symptoms of aggression and irritability that had not responded to previous treatment. In both cases, risperidone significantly reduced aggression and improved social relatedness. One patient's treatment with risperidone was complicated by persistent tachycardia and QT(C) interval prolongation that was dose-related. Consideration should be given to the appropriate use of medication in the treatment of very young children with autism when other interventions do not prove helpful.

    UR - http://www.scopus.com/inward/record.url?scp=0033461141&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0033461141&partnerID=8YFLogxK

    M3 - Article

    VL - 9

    SP - 273

    EP - 276

    JO - Journal of Child and Adolescent Psychopharmacology

    JF - Journal of Child and Adolescent Psychopharmacology

    SN - 1044-5463

    IS - 4

    ER -